Remove Bioavailability Remove Contract Manufacturing Remove Marketing Remove Pharmacy
article thumbnail

Small molecule API: Shining a spotlight on new innovations in milling

Pharmaceutical Technology

The ingredients used in these drugs are high potency, even at small doses, and pose a risk to both human health and cross-contamination with other drugs in a manufacturing environment. A robust manufacturing process that leads to a consistently high-quality product is a major business goal for pharmaceutical R&D.

article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

The number of high-potency drug approvals has increased over the last decade, driven by the increasing use of APIs (Active Pharmaceutical Ingredients) in the pipeline and among marketed drugs. Furthermore, the number of marketed high potency APIs (HPAPIs) tends to increase over time as more HPAPIs in development gain approval.